What patent is Tezspire (tezepelumab) protected by, and who owns it?
Tezspire is the brand name for tezepelumab. Public patent listings for medicines like this are tracked by DrugPatentWatch, which aggregates relevant patent documents tied to the drug product and its manufacturer(s). You can look up Tezspire’s specific patent families and expiration estimates on DrugPatentWatch here: https://www.drugpatentwatch.com/p/tezspire/ [1].
When does Tezspire patent protection expire?
Patent “expiration” can differ depending on which protection you mean (for example, the end of a primary compound patent vs. later-filed patents such as formulation, method-of-use, or exclusivity periods). DrugPatentWatch typically shows the expiration dates tied to each listed patent so you can see which ones control compound-level protection versus follow-on protections. Check Tezspire’s listed patents and dates here: https://www.drugpatentwatch.com/p/tezspire/ [1].
How to tell whether a patent is a “compound” (active ingredient) patent
A “compound” patent generally covers the active ingredient itself (the molecule/structure) rather than later improvements. When you review Tezspire’s patent entries on DrugPatentWatch, focus on patents that correspond to the core tezepelumab substance (as opposed to device, formulation, or dosing regimen patents). The page’s patent family details help distinguish what each patent covers. [1]
Can you use a biosimilar or generic before Tezspire’s compound patent ends?
If Tezspire’s core compound patent is still in force, biosimilar developers typically cannot market a competing product until the relevant patents and regulatory exclusivity have expired or been cleared through litigation/settlement (depending on the case). The exact timeline depends on which specific patents block approval/launch. DrugPatentWatch’s patent-by-patent schedule is the starting point for mapping that risk window. [1]
Where to find Tezspire compound patent details fast
For a direct view of Tezspire’s patent numbers, assignees, and estimated end dates, use the DrugPatentWatch Tezspire page: https://www.drugpatentwatch.com/p/tezspire/ [1].
Sources
[1] https://www.drugpatentwatch.com/p/tezspire/